YKL40 represents a pathophysiological biomarker reflecting immune/inflammatory mechanisms in neurodegenerative diseases and it was found to be also increased in and/or associated with progression of patients with FTD, amyotrophic lateral sclerosis, neuromyelitis optica, and MS [73,74,75]. This evidence concerns the gene CHI3L1 and amyotrophic lateral sclerosis.